Eskander M B, Limb D, Stone M H, Furlong A J, Shardlow D, Stead D, Culleton G
Academic Department of Orthopaedic Surgery, General Infirmary, Leeds, UK.
Int Orthop. 1997;21(4):259-61. doi: 10.1007/s002640050162.
Two hundred and thirty-eight patients with femoral neck fractures were entered into a randomised pilot study comparing the use of sequential treatment by 'Flowtron DVT' garments in the perioperative period followed by Enoxaparin (Clexane-Rhône-Poulenc Rorer), and Enoxaparin alone. One hundred and ninety-three patients were excluded indicating the difficulty of achieving pure comparisons in this population. The remaining 44 were randomised: 21 received Enoxaparin from the time of admission, and 23 had sequential treatment. There was no statistically significant difference in the incidence of thromboembolism. Patient preference did not indicate a favoured treatment subjectively. The operation field was drier in the sequential group, although this did not reach significance. Sequential treatment was not shown to be better or worse than treatment with Enoxaparin, but the trends favoured sequential treatment rather than drug treatment alone. The technique allows the operation to be carried out without the problems produced by low dose heparins and mobilisation is not hindered by compression garments.
238例股骨颈骨折患者进入一项随机试验研究,比较围手术期使用“Flowtron DVT”服装序贯治疗联合依诺肝素(克赛 - 罗纳 - 普朗克 - 罗瑞尔公司生产)与单纯使用依诺肝素的效果。193例患者被排除,这表明在此类人群中进行纯粹比较存在困难。其余44例患者被随机分组:21例从入院时起接受依诺肝素治疗,23例接受序贯治疗。血栓栓塞发生率无统计学显著差异。患者偏好并未主观显示出对某种治疗的青睐。序贯治疗组的术野更干燥,尽管未达到显著水平。序贯治疗并不比依诺肝素治疗更好或更差,但趋势更倾向于序贯治疗而非单纯药物治疗。该技术使得手术能够在不出现低剂量肝素所产生问题的情况下进行,且活动不受加压服装的阻碍。